Quest Diagnostics Incorporated (DGX): Price and Financial Metrics

DGX POWR Grades

• DGX scores best on the Quality dimension, with a Quality rank ahead of 93.17% of US stocks.
• DGX's strongest trending metric is Growth; it's been moving down over the last 51 weeks.
• DGX ranks lowest in Momentum; there it ranks in the 24th percentile.

DGX Stock Summary

• With a price/earnings ratio of 7.74, Quest Diagnostics Inc P/E ratio is greater than that of about just 12.74% of stocks in our set with positive earnings.
• In terms of twelve month growth in earnings before interest and taxes, Quest Diagnostics Inc is reporting a growth rate of 170.68%; that's higher than 87.18% of US stocks.
• Quest Diagnostics Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 16.56%, greater than the shareholder yield of 87.2% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to Quest Diagnostics Inc, a group of peers worth examining would be LEA, PKG, STLD, BAH, and ATKR.
• DGX's SEC filings can be seen here. And to visit Quest Diagnostics Inc's official web site, go to www.questdiagnostics.com.

DGX Valuation Summary

• In comparison to the median Healthcare stock, DGX's EV/EBIT ratio is 75.09% lower, now standing at 7.3.
• Over the past 243 months, DGX's price/sales ratio has gone down 0.
• Over the past 243 months, DGX's price/sales ratio has gone down 0.

Below are key valuation metrics over time for DGX.

DGX Growth Metrics

• Its year over year net income to common stockholders growth rate is now at 127.11%.
• Its 4 year net income to common stockholders growth rate is now at 5.73%.
• The year over year net cashflow from operations growth rate now stands at 104.86%.

Over the past 30 months, DGX's revenue has gone up $3,527,000,000.

The table below shows DGX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	11,058	2,594	2,247
2021-03-31	10,335	2,489	1,801
2020-12-31	9,437	2,005	1,431
2020-09-30	8,361	1,812	1,105
2020-06-30	7,531	1,249	752
2020-03-31	7,657	1,215	793

DGX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• DGX has a Quality Grade of B, ranking ahead of 93.21% of graded US stocks.
• DGX's asset turnover comes in at 0.805 -- ranking 32nd of 81 Healthcare stocks.
• SSY, LH, and TDOC are the stocks whose asset turnover ratios are most correlated with DGX.

The table below shows DGX's key quality metrics over time.